Tolvaptan slows disease progression in late-stage ADPKD
Crossref DOI link: https://doi.org/10.1038/nrneph.2017.180
Published Online: 2018-01-02
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ong, Albert C. M.
Text and Data Mining valid from 2018-01-02
Article History
First Online: 2 January 2018
Competing interests
: A.C.M.O. was a site investigator in the TEMPO and REPRISE studies and has received research funding from Otsuka Pharmaceuticals.